| Original language | English (US) |
|---|---|
| Pages (from-to) | 1776-1777 |
| Number of pages | 2 |
| Journal | Journal of Allergy and Clinical Immunology |
| Volume | 133 |
| Issue number | 6 |
| DOIs | |
| State | Published - Jun 2014 |
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
Reply. / Szefler, Stanley J.; Chmiel, James F.; Fitzpatrick, Anne M.; Giacoia, George; Green, Thomas P.; Jackson, Daniel J.; Nielsen, Heber C.; Phipatanakul, Wanda; Raissy, Hengameh H.
In: Journal of Allergy and Clinical Immunology, Vol. 133, No. 6, 06.2014, p. 1776-1777.Research output: Contribution to journal › Letter › peer-review
TY - JOUR
T1 - Reply
AU - Szefler, Stanley J.
AU - Chmiel, James F.
AU - Fitzpatrick, Anne M.
AU - Giacoia, George
AU - Green, Thomas P.
AU - Jackson, Daniel J.
AU - Nielsen, Heber C.
AU - Phipatanakul, Wanda
AU - Raissy, Hengameh H.
N1 - Funding Information: Disclosure of potential conflict of interest: S. J. Szefler has received consultancy fees from Merck, Genentech, Boehringer Ingelheim, and GlaxoSmithKline; has received research support from GlaxoSmithKline ; has received lecture fees from Merck; has received payment for manuscript preparation from Genentech; and has a pending patent with the National Heart, Lung, and Blood Institute (NHLBI) CARE Network for a beta adrenergic receptor polymorphism. J. F. Chmiel has received consultancy fees from Genentech, CSL Behring, and Boehringer Ingelheim; has received research support and honoraria for grant reviews from the National Institutes of Health and the Cystic Fibrosis Foundation ; has received payment for the development of educational presentations from KaloBios Pharmaceuticals; has received travel support from the American College of Chest Physicians; and has received honorarium from the American Board of Pediatrics for question writing activities. A. M. Fitzpatrick has received consultancy fees from MedImmune, Merck, GlaxoSmithKline, Genentech, and Boehringer Ingelheim. D. J. Jackson has received consultancy fees from GlaxoSmithKline and Genentech. W. Phipatanakul has received research support from the National Institutes of Health . H. H. Raissy has received research support from the NHLBI /subcontract with National Jewish Health and has received travel support from Genentech. The rest of the authors declare that they have no relevant conflicts of interest.
PY - 2014/6
Y1 - 2014/6
UR - http://www.scopus.com/inward/record.url?scp=84901745045&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84901745045&partnerID=8YFLogxK
U2 - 10.1016/j.jaci.2014.03.013
DO - 10.1016/j.jaci.2014.03.013
M3 - Letter
C2 - 24786239
AN - SCOPUS:84901745045
VL - 133
SP - 1776
EP - 1777
JO - Journal of Allergy and Clinical Immunology
JF - Journal of Allergy and Clinical Immunology
SN - 0091-6749
IS - 6
ER -